This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biocryst Pharmaceuticals Inc (BCRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 21.16M 20.89M 16.44M 13.62M
Receivables 2.12M 4.56M 7.57M 30.23M
Inventories 0.00 0.00 263.00K 898.08K
Other Current Assets 75.00K 0.00 2.30M 0.00
Total Current Assets 42.12M 41.98M 52.86M 87.42M
Property, Plant & Equipment, Gross 14.41M 14.93M 14.87M 14.81M
Accumulated Depreciation & Depletion 14.11M 14.35M 13.77M 12.88M
Property, Plant & Equipment, Net 306.00K 583.00K 1.10M 1.93M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 6.44M 9.84M 28.25M 11.77M
Total Non-Current Assets 6.74M 15.46M 29.35M 22.03M
Liabilities & Shareholder Equity
Total Assets 48.87M 57.44M 82.21M 109.45M
Accounts Payable 4.17M 3.97M 2.50M 8.20M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 52.54K
Total Current Liabilities 15.26M 17.22M 26.30M 27.82M
Long Term Debt 30.00M 30.00M 30.00M 0.00
Deferred Income Taxes 0.00 0.00 0.00 177.61K
Other Non-Current Liabilities 4.74M 10.67M 11.10M 15.94M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 34.74M 40.67M 41.10M 16.12M
Total Liabilities 49.99M 57.89M 67.40M 43.94M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -1.13M -454.00K 14.81M 65.50M
Common Par 591.00K 509.00K 457.00K 449.59K
Additional Paid In Capital 420.99M 391.61M 367.83M 361.52M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -422.71M -392.60M -353.52M -296.57M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 4.00K 27.00K 40.00K 105.71K
Total Capitalization 28.87M 29.55M 44.81M 65.50M
Total Equity -1.13M -454.00K 14.81M 65.50M
Total Liabilities & Stock Equity 48.87M 57.44M 82.21M 109.45M
Total Common Shares Outstanding 59.09M 50.89M 45.66M 44.96M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 55.22M 49.47M 45.14M 44.56M
Diluted Weighted Shares Outstanding 55.22M 49.47M 45.14M 44.56M
Number of Employees 40 40 75 76
Number of Part-Time Employees 0 0 0 0

BCRX Biocryst Pharmaceuticals Inc

Analysts Ratings for BCRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 8 7
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

Brokerage Partners

BCRX Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs